Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Tryptophan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.89 |
| ▸ | MAPT | P10636 | 3/20 | 0.89 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.89 |
| ▸ | LMNA | P02545 | 2/20 | 0.89 |
| ▸ | TSHR | P16473 | 2/20 | 0.89 |
| ▸ | BLM | P54132 | 2/20 | 0.89 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.89 |
| ▸ | MEN1 | O00255 | 2/20 | 0.89 |
| ▸ | MPO | P05164 | 1/20 | 0.89 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | APAF1 | O14727 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | HTR2A | P28223 | 3/20 | 0.61 |
| ▸ | HTR1A | P08908 | 2/20 | 0.61 |
| ▸ | HTR2C | P28335 | 2/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tryptophan SCHEMBL1675340 | 1.00 | KDM4E (0.89) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL424582 | 1.00 | KDM4E (0.89) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL27137714 | 1.00 | KDM4E (0.89) | KDM4EMAPTKMT2ALMNATSHR | |
| Dl-Tryptophan SCHEMBL7056081 | 1.00 | KDM4E (0.89) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL7056086 | 1.00 | KDM4E (0.89) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL6046200 | 0.95 | KMT2A (0.80) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL4287329 | 0.95 | KDM4E (0.80) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL6033338 | 0.95 | KDM4E (0.80) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL7103661 | 0.95 | KDM4E (0.80) | KDM4EMAPTKMT2ALMNATSHR | |
| Tryptophan SCHEMBL23141133 | 0.94 | KMT2A (1.00) | KDM4EMAPTKMT2ALMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117599013-A | Nanometer composition, preparation method and application thereof | 赣州和美药业股份有限公司 | 2024-02-27 | — | — | CN | claimed |
| US-20230258556-A1 | Nanozeolites and their Analytical Use as Chemosensors in Biorelevant Media | Karlsruher Institut für Technologie (DE) | 2023-08-17 | — | — | US | claimed |
| CN-116444685-A | Efficient controllable RNA delivery system | 清华大学 | 2023-07-18 | — | — | CN | claimed |
| CN-113912524-A | Polypeptide compound containing sulfamide and synthesis method thereof | 华东师范大学 | 2022-01-11 | — | — | CN | claimed |
| CN-106478771-A | A kind of synthetic method of amino acid neural tetrapeptide | 李世军 | 2017-03-08 | — | — | CN | claimed |
| CN-106279354-A | A kind of synthetic method of amino acid neural dipeptides | 温州医科大学 | 2017-01-04 | — | — | CN | claimed |
| US-9164106-B2 | Determination of decreased metabolism of tryptophan in diagnosis of autism spectrum disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2015-10-20 | — | — | US | claimed |
| US-20150183822-A1 | ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE | YAMAKI CO., LTD. (JP) | 2015-07-02 | — | — | US | claimed |
| CN-104583227-A | Angiotensin-converting-enzyme inhibiting dipeptide | YAMAKI CO LTD | 2015-04-29 | — | — | CN | claimed |
| US-20130244273-A1 | Determination of Decreased Metabolism of Tryptophan in Diagnosis of Autism Spectrum Disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2013-09-19 | — | — | US | claimed |
| US-20100297680-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIVERSITY OF WASHINGTON (US) | 2010-11-25 | — | — | US | claimed |
| US-20080261250-A1 | Methods for Assessing the Risk for Development of Cardiovascular Disease | UNIVERSITY OF WASHINGTON (US) | 2008-10-23 | — | — | US | claimed |
| EP-1787116-A4 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIV WASHINGTON (US) | 2008-05-28 | — | — | EP | claimed |
| EP-1787116-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | University of Washington (US) | 2007-05-23 | — | — | EP | claimed |
| US-20060182652-A1 | Methods for sterilizing biological materials using dipeptide stabilizers | CLEARANT INC. | 2006-08-17 | — | — | US | claimed |
| WO-2006014628-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIVERSITY OF WASHINGTON (US) | 2006-02-09 | — | — | WO | claimed |
| EP-0555087-B1 | Peritoneal dialysis solutions containing at least one dipeptide | BAXTER INT (US) | 1998-08-05 | — | — | EP | claimed |
| US-5597805-A | Peritoneal dialysis solutions | BAXTER INTERNATIONAL INC. (US) | 1997-01-28 | — | — | US | claimed |
| US-4340592-A | OLICOPEPTIDES FOR DIETARY PURPOSES | ADIBI SIAMAK A | 1982-07-20 | — | — | US | claimed |
| CN-117599013-A | Nanometer composition, preparation method and application thereof | 赣州和美药业股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| WO-2024015916-A2 | 4'-ALKYNE-2'-DEOXYCYTIDINE-BASED COMPOUNDS AND ANTI-CANCER USES THEREOF | THOMAS JEFFERSON UNIVERSITY (US) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024006854-A2 | HYPOIMMUNOGENIC BIOMIMETIC NANOVESICLE GENE EDITING SYSTEM FOR HIV INFECTION | MALCOLM THOMAS (US) | 2024-01-04 | — | — | WO | disclosed |
| CN-116507349-A | Probiotic bacillus compositions and methods of use | 生物编辑有限责任公司 | 2023-07-28 | — | — | CN | disclosed |
| CN-116444685-A | Efficient controllable RNA delivery system | 清华大学 | 2023-07-18 | — | — | CN | disclosed |
| US-20230158222-A1 | DEVICES AND METHODS FOR TREATING A CORONAVIRUS INFECTION AND SYMPTOMS THEREOF | AETHLON MEDICAL, INC. | 2023-05-25 | — | — | US | disclosed |
| WO-2023064753-A1 | DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF | AETHLON MEDICAL, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| CN-115232192-B | Azo type hypoxic response type dipeptide supramolecular monomer and preparation method and application thereof | 济宁医学院 | 2023-03-28 | — | — | CN | disclosed |
| EP-4136453-A1 | DEVICES AND METHODS FOR TREATING A CORONAVIRUS INFECTION AND SYMPTOMS THEREOF | Aethlon Medical, Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| CN-115232192-A | Azo hypoxic response type dipeptide supramolecular monomer and preparation method and application thereof | 济宁医学院 | 2022-10-25 | — | — | CN | disclosed |
| CN-114574612-A | Methods and compositions for producing short shoot corn plants | 孟山都技术有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-113683661-B | Dual-response dipeptide supramolecular polymer and preparation method and application thereof | 济宁医学院 | 2022-03-11 | — | — | CN | disclosed |
| CN-113683661-B | Dual-response dipeptide supramolecular polymer and preparation method and application thereof | 济宁医学院 | 2022-03-11 | — | — | CN | disclosed |
| CN-107849570-B | Methods and compositions for producing short shoot corn plants | 孟山都技术有限公司 | 2022-02-15 | — | — | CN | disclosed |
| CN-113912524-A | Polypeptide compound containing sulfamide and synthesis method thereof | 华东师范大学 | 2022-01-11 | — | — | CN | disclosed |
| CN-113683661-A | Dual-response dipeptide supramolecular polymer and preparation method and application thereof | 济宁医学院 | 2021-11-23 | — | — | CN | disclosed |
| CN-113683661-A | Dual-response dipeptide supramolecular polymer and preparation method and application thereof | 济宁医学院 | 2021-11-23 | — | — | CN | disclosed |
| WO-2021211351-A1 | DEVICES AND METHODS FOR TREATING A CORONAVIRUS INFECTION AND SYMPTOMS THEREOF | AETHLON MEDICAL, INC. (US) | 2021-10-21 | — | — | WO | disclosed |
| CN-113262288-A | External activating fascia health-care bag and manufacturing and using methods thereof | 厦门寿甫医疗科技有限公司 | 2021-08-17 | — | — | CN | disclosed |
| US-10590188-B2 | Antibody | QUEEN MARY UNIVERSITY OF LONDON (GB) | 2020-03-17 | — | — | US | disclosed |
| US-10456736-B2 | Method and apparatus for purification and treatment of air | PALOZA LLC (US) | 2019-10-29 | — | — | US | disclosed |
| US-20180244802-A1 | ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY | DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN E.V. (DZNE) (DE) | 2018-08-30 | — | — | US | disclosed |
| EP-3277083-A1 | ORGAN PRESERVATION COMPOSITION | TX Innovations B.V. (NL) | 2018-02-07 | — | — | EP | disclosed |
| CN-107156652-A | A kind of preparation method and its usage of multi-functional edible material | 江苏大学 | 2017-09-15 | — | — | CN | disclosed |
| CN-107098952-A | Antibacterial ring（Glycine tryptophan leucine D leucine valine asparagines）The preparation method of peptide | 安徽工程大学 | 2017-08-29 | — | — | CN | disclosed |
| US-20170129948-A1 | Antibody | QUEEN MARY UNIVERSITY OF LONDON (GB) | 2017-05-11 | — | — | US | disclosed |
| US-20170106333-A1 | Method and Apparatus for Purification and Treatment of Air | PALOZA LLC | 2017-04-20 | — | — | US | disclosed |
| EP-3155012-A2 | AUTOANTIBODIES ASSOCIATED WITH RHEUMATOID ARTHRITIS | Queen Mary University of London (GB) | 2017-04-19 | — | — | EP | disclosed |
| CN-104931628-B | Fe3O4-COOH magnetic nano-material modified open tubular column as well as preparation method and application thereof | 华南师范大学 | 2017-03-22 | — | — | CN | disclosed |
| CN-106478771-A | A kind of synthetic method of amino acid neural tetrapeptide | 李世军 | 2017-03-08 | — | — | CN | disclosed |
| US-20170016924-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIVERSITY OF WASHINGTON (US) | 2017-01-19 | — | — | US | disclosed |
| CN-106279354-A | A kind of synthetic method of amino acid neural dipeptides | 温州医科大学 | 2017-01-04 | — | — | CN | disclosed |
| WO-2016159773-A1 | ORGAN PRESERVATION COMPOSITION | TX INNOVATIONS B.V. (NL) | 2016-10-06 | — | — | WO | disclosed |
| CN-105992594-A | Antibodies specific for enteroviruses that infect humans | MAB探索私人有限公司 | 2016-10-05 | — | — | CN | disclosed |
| WO-2015189638-A2 | ANTIBODY | QUEEN MARY UNIVERSITY OF LONDON (GB) | 2015-12-17 | — | — | WO | disclosed |
| US-9164106-B2 | Determination of decreased metabolism of tryptophan in diagnosis of autism spectrum disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2015-10-20 | — | — | US | disclosed |
| US-20150183822-A1 | ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE | YAMAKI CO., LTD. (JP) | 2015-07-02 | — | — | US | disclosed |
| CN-104583227-A | Angiotensin-converting-enzyme inhibiting dipeptide | YAMAKI CO LTD | 2015-04-29 | — | — | CN | disclosed |
| CN-102046520-B | Method of producing composition of hypochlorous acid and use thereof | AQUILABS S A | 2013-11-20 | — | — | CN | disclosed |
| US-8586759-B2 | Methods and systems for synthesis of a D-aminoluciferin precursor and related compounds | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2013-11-19 | — | — | US | disclosed |
| US-20130244273-A1 | Determination of Decreased Metabolism of Tryptophan in Diagnosis of Autism Spectrum Disorders | GREENWOOD GENETIC CENTER, INC. (US) | 2013-09-19 | — | — | US | disclosed |
| EP-2616481-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | Aligna Technologies, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012036884-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
| US-20120021923-A1 | METHODS AND SYSTEMS TO DIAGNOSE A CONDITION IN AN INDIVIDUAL | NATIONAL SCIENCE FOUNDATION | 2012-01-26 | — | — | US | disclosed |
| US-20110275524-A1 | METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE | NATIONAL SCIENCE FOUNDATION | 2011-11-10 | — | — | US | disclosed |
| US-20110224442-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (LLNS) | 2011-09-15 | — | — | US | disclosed |
| US-20110213124-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2011-09-01 | — | — | US | disclosed |
| CN-102046520-A | Method of producing composition of hypochlorous acid and use thereof | AQUILABS S A | 2011-05-04 | — | — | CN | disclosed |
| US-20100297680-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIVERSITY OF WASHINGTON (US) | 2010-11-25 | — | — | US | disclosed |
| US-7749729-B2 | Methods for assessing the risk for development of cardiovascular disease | UNIVERSITY OF WASHINGTON (US) | 2010-07-06 | — | — | US | disclosed |
| US-20100143364-A1 | Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders | VYBION, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| CN-100595277-C | Form board stationary beta hair clip ring analog and use in bacteriophage exhibition | POLYPHOR LTD | 2010-03-24 | — | — | CN | disclosed |
| US-20080261250-A1 | Methods for Assessing the Risk for Development of Cardiovascular Disease | UNIVERSITY OF WASHINGTON (US) | 2008-10-23 | — | — | US | disclosed |
| EP-1787116-A4 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIV WASHINGTON (US) | 2008-05-28 | — | — | EP | disclosed |
| EP-1536834-A4 | DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES | CHEMOKINE THERAPEUTICS CORP (US) | 2007-11-07 | — | — | EP | disclosed |
| CN-1984558-A | Novel herbicide resistance gene | DOW AGROSCIENCES LLC (US) | 2007-06-20 | — | — | CN | disclosed |
| EP-1787116-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | University of Washington (US) | 2007-05-23 | — | — | EP | disclosed |
| CN-1918296-A | Toxin complex proteins and genes from xenorhabdus bovienii | DOW AGROSCIENCES LLC (US) | 2007-02-21 | — | — | CN | disclosed |
| CN-1910280-A | Template-fixed beta hairpin loop mimetics and their use in phage display | POLYPHOR LTD (CH) | 2007-02-07 | — | — | CN | disclosed |
| EP-0892054-B1 | Clostridium perfringens vaccine | INTERVET INT BV (NL) | 2006-11-29 | — | — | EP | disclosed |
| WO-2006014628-A1 | METHODS FOR ASSESSING THE RISK FOR DEVELOPMENT OF CARDIOVASCULAR DISEASE | UNIVERSITY OF WASHINGTON (US) | 2006-02-09 | — | — | WO | disclosed |
| CN-1684974-A | Pesticidally active proteins and polynucleotides obtainable from paenibacillus species | DOW AGROSCIENCES LLC (US) | 2005-10-19 | — | — | CN | disclosed |
| EP-1536834-A2 | DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES | Chemokine Therapeutics Corp. (US) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004024088-A2 | DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES | CHEMOKINE THERAPEUTICS CORP. (US) | 2004-03-25 | — | — | WO | disclosed |
| US-6610300-B1 | Detoxified immunogenic derivatives of Clostridium perfringens beta -toxin or an immunogenic fragment thereof that have as a characteristic that they carry a mutation in the beta -toxin amino acid sequence, not found in the wild-type beta toxin | AKZO NOBEL N.V. (NL) | 2003-08-26 | — | — | US | disclosed |
| US-20030099689-A1 | For aquatic animals, intended for oral administration and including mixture of synthetic peptide molecules representing 6-50% by weight of total formulation and include amino acid residues of all of the indispensable amino acids | OHIO STATE RESEARCH FOUNDATION | 2003-05-29 | — | — | US | disclosed |
| EP-0804931-B1 | Peritoneal dialysis solutions and their use to minimize injury to mesothelial cells | BAXTER INT (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1007532-A1 | OLIGONUCLEOTIDES FOR IDENTIFYING PRECURSORS OF AMIDATED POLYPEPTIDE HORMONES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2000-06-14 | — | — | EP | disclosed |
| US-5955450-A | Peritoneal dialysis solutions and methods usable to minimize the injury and adverse physiological effects caused by peritonitis | BAXTER INTERNATIONAL INC. (US) | 1999-09-21 | — | — | US | disclosed |
| EP-0726936-B1 | LIQUID DETERGENTS WITH ORTHO-SUBSTITUTED PHENYLBORONIC ACIDS FOR INHIBITION OF PROTEOLYTIC ENZYME | PROCTER & GAMBLE (US) | 1999-05-19 | — | — | EP | disclosed |
| WO-1999010361-A1 | OLIGONUCLEOTIDES FOR IDENTIFYING PRECURSORS OF AMIDATED POLYPEPTIDE HORMONES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1999-03-04 | — | — | WO | disclosed |
| EP-0892054-A1 | Clostridium perfringens vaccine | Akzo Nobel N.V. (NL) | 1999-01-20 | — | — | EP | disclosed |
| EP-0555087-B1 | Peritoneal dialysis solutions containing at least one dipeptide | BAXTER INT (US) | 1998-08-05 | — | — | EP | disclosed |
| EP-0804931-A2 | Peritoneal dialysis solutions and their use to minimize injury to mesothelial cells | BAXTER INTERNATIONAL INC. (US) | 1997-11-05 | — | — | EP | disclosed |
| US-5597805-A | Peritoneal dialysis solutions | BAXTER INTERNATIONAL INC. (US) | 1997-01-28 | — | — | US | disclosed |
| EP-0726936-A1 | LIQUID DETERGENTS WITH ORTHO-SUBSTITUTED PHENYLBORONIC ACIDS FOR INHIBITION OF PROTEOLYTIC ENZYME | THE PROCTER & GAMBLE COMPANY (US) | 1996-08-21 | — | — | EP | disclosed |
| US-5438118-A | Peptide mimics having constrained peptide backbone | SMITHKLINE BEECHMAN CORP. (US) | 1995-08-01 | — | — | US | disclosed |
| US-5436127-A | Polypeptides for antibodies | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| WO-1995012655-A1 | LIQUID DETERGENTS WITH ORTHO-SUBSTITUTED PHENYLBORONIC ACIDS FOR INHIBITION OF PROTEOLYTIC ENZYME | THE PROCTER & GAMBLE COMPANY (US) | 1995-05-11 | — | — | WO | disclosed |
| EP-0555087-A1 | Peritoneal dialysis solutions containing at least one dipeptide | BAXTER INTERNATIONAL INC. (US) | 1993-08-11 | — | — | EP | disclosed |
| WO-1993014796-A1 | PERITONEAL DIALYSIS COMPOSITION AND METHOD USABLE DURING AND AFTER PERITONITIS | BAXTER INTERNATIONAL, INC. (US) | 1993-08-05 | — | — | WO | disclosed |
| US-5194600-A | Genes which participate in β-glucan assembly and use thereof | ROYAL INSTITUTE FOR THE ADVANCEMENT OF LEARNING (CA) | 1993-03-16 | — | — | US | disclosed |
| US-5061693-A | Hexapeptides, anticoagulants | MERCK & CO., INC. (US) | 1991-10-29 | — | — | US | disclosed |
| US-4798778-A | ETHYLENE POLYMER WITH CARBOXY ACID DERIVATIVE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-01-17 | — | — | US | disclosed |
| US-4393201-A | DEOXYRIBONUCLEIC ACID | THE WISTAR INSTITUTE (US) | 1983-07-12 | — | — | US | disclosed |
| US-4393201-A | DEOXYRIBONUCLEIC ACID | THE WISTAR INSTITUTE (US) | 1983-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224442-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | HCCS, HLCS, GLUL | ADORA3 2359/4885KDM4E 4005/4885MAPT 4518/4885 |
| US-20100143364-A1 | Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders | CES2, CHRNA5, CHRNA3 | ADORA3 510/4885KDM4E 1096/4885MAPT 61/4885 |
| US-20110213124-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | HCCS, HLCS, GLUL | ADORA3 2359/4885KDM4E 4005/4885MAPT 4518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.